Cellosaurus NUGC-3/5-FU/L (CVCL_L502)

Cell line name NUGC-3/5-FU/L
Synonyms NUGC-3/5FU/L; NUGC-3/5-FU; NUGC-3/5FU
Accession CVCL_L502
Resource Identification Initiative To cite this cell line use: NUGC-3/5-FU/L (RRID:CVCL_L502)
Comments Part of: JFCR45 cancer cell line panel.
Selected for resistance to: ChEBI; CHEBI:46345; 5-fluorouracil (5-FU).
Disease Gastric adenocarcinoma (NCIt: C4004)
Derived from metastatic site: Brachialis muscle.
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Hierarchy Parent: CVCL_1612 (NUGC-3)
Sex of cell Male
Category Cancer cell line
Publications

PubMed=8609072; DOI=10.1111/j.1349-7006.1996.tb03161.x
Inaba M., Mitsuhashi J., Sawada H., Miike N., Naoe Y., Daimon A., Koizumi K., Tsujimoto H., Fukushima M.
Reduced activity of anabolizing enzymes in 5-fluorouracil-resistant human stomach cancer cells.
Jpn. J. Cancer Res. 87:212-220(1996)

PubMed=10359051; DOI=10.1111/j.1349-7006.1999.tb00754.x
Inaba M., Sawada H., Sadata A., Hamada H.
Circumvention of 5-fluorouracil resistance in human stomach cancer cells by uracil phosphoribosyltransferase gene transduction.
Jpn. J. Cancer Res. 90:349-354(1999)

PubMed=15767549; DOI=10.1158/1535-7163.MCT-04-0234
Nakatsu N., Yoshida Y., Yamazaki K., Nakamura T., Dan S., Fukui Y., Yamori T.
Chemosensitivity profile of cancer cell lines and identification of genes determining chemosensitivity by an integrated bioinformatical approach using cDNA arrays.
Mol. Cancer Ther. 4:399-412(2005)